期刊论文详细信息
Current Oncology
Efficacy and tolerability of toremifene and tamoxifen therapy in premenopausal patients with operable breast cancer: a retrospective analysis
B. Bai2  Y.D. Zeng1  Y.X. Shi2  D.G. Liu2  R.J. Peng2  S.S. Wang2  Z.Y. Yuan2  T. Qin2  X.Y. Teng2 
[1] Sun Yat-sen University;Sun Yat-sen University Cancer Center
关键词: Tamoxifen;    toremifene;    breast cancer;    adjuvant endocrine therapy;    premenopausal;   
DOI  :  
学科分类:肿瘤学
来源: Multimed, Inc.
PDF
【 摘 要 】

Background Given the use of tamoxifen as standard treatment for hormone receptor–positive breast cancer, the use of toremifene as an adjuvant endocrine therapy has not been widely examined. The present retrospective study compared the efficacy and safety of toremifene and tamoxifen in the treatment of operable hormone receptor–positive breast cancer in premenopausal women. Methods Premenopausal patients with hormone receptor– positive operable breast cancer were eligible. Enrolled patients ( n= 1847) received either 60 mg toremifene ( n= 396) or 20 mg tamoxifen ( n= 1451) daily for a minimum of 5 years after surgery. Disease-free survival (dfs) was the primary endpoint. Overall survival (os) and time to distant recurrence were secondary endpoints. Results Treatment with toremifene and tamoxifen resulted in no between-group differences in dfs ( p= 0.659) or os ( p= 0.364). Mean dfs was 10.3 years for both groups. Mean os was 11.2 years for the toremifene group and 11.1 years for tamoxifen group. The 5-year dfs rate was 87.0% in the toremifene group and 85.0% in the tamoxifen group. The 5-year survival rate was 94.3% in the toremifene group and 93.5% in the tamoxifen group. Adverse events rates were similar in the two groups, with the exception of irregular menses, which occurred at a higher rate in the tamoxifen group than in the toremifene group (10.0% vs. 6.3%,p= 0.025). Conclusions In this retrospective study, the efficacy and safety profiles of toremifene and tamoxifen for the treatment of operable hormone receptor–positive breast cancer in premenopausal women were similar.

【 授权许可】

Unknown   

【 预 览 】
附件列表
Files Size Format View
RO201912050597858ZK.pdf 564KB PDF download
  文献评价指标  
  下载次数:5次 浏览次数:12次